Surgery
Reinvented
Play Again
Discover
The next breakthrough isn’t another drug,
it’s surgery.
Surgery is the most effective tool we have to treat, and cure, cancer and other serious conditions. While millions of people undergo surgery each year with a market size greater than $3 trillion in the United States alone, surgical innovation remains trapped in yesterday’s technology.
We are reinventing surgery for the modern era.
See precisely.
Cure precisely.
A new ultrasound technology stack gives surgeons millimeter-level control for precision treatment of malignant tissue.
AI + Ultrasound =
Digital Surgery
AI-driven algorithms process real-time imaging data, enhancing surgeon precision and confidence during even the most complex procedures, making this the first true digital surgery platform.
Automated Surgery =
Better Outcomes
Closed-loop control gives every surgeon the consistency, finesse, and repeatability of a master—improving outcomes, reducing risk, and minimizing human error in high-stakes procedures.
Smart Platform =
More Conditions Treated
Real-time visualization, precision ultrasound, and AI-enabled control allow treatment of tumors, chronic pain, heart failure, and hypertension—while each case trains the system for the next.
Backed by elite investors & institutions
A growth path to health
Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail. These cases are an $3 billion market subset within the larger oncology space.
While oncology remains our focus, our platform offers precision and adaptability to transform precision medicine across fields like cardiac arrhythmia, chronic pain, hypertension, and epilepsy.
2025
Oncology
2027
Cardiac Arrhythmia
2029
Chronic Pain
2030
Hypertension
2032
Epilepsy
The Future
Surgery will
evolve with us.
The Future
Surgery will
evolve with us.
The Future
Surgery will
evolve with us.
Meet our team
Unparalleled expertise in surgical robotics, ultrasound, deep learning, and commercializing medical technology.
Al Mashal, Ph.D.
CEO / CoFounder
Andrew Durette
Software Engineer
Chris Wagner, Ph.D.
CTO / CoFounder
Fred Hamlin, Ph.D.
Principal Mechanical Engineer
Heyuan Huang, Ph.D.
Deep Learning Scientist
Julien Grondin, Ph.D.
Principal Ultrasound Engineer
Matthieu Gros
Mechanical Engineer
Nick Pett
Mechanical Engineer
Join us!
See Openings
Unparalleled expertise in surgical robotics, ultrasound, deep learning, and commercializing medical technology.
The Current Surgical team spans surgery, biomedical engineering, imaging, and robotics.
We’ve experienced firsthand the limitations of existing tools and are building what today’s OR actually needs.
With backgrounds at places like Johns Hopkins and Harvard, we’ve developed FDA-cleared devices, led clinical trials, and built scalable medical systems—blending precision with practicality at every step.
Newsroom
September 28, 2022
Current Surgical Presents at the Inaugural Mayo Clinic Beahrs Surgical Innovation Summit / PR Newswire
View
July 12, 2023
Current Surgical Receives $400k Grant from NIH's National Cancer Institute to Develop Surgery Platform for Early-Stage Cancer / PR Newswire
View
June 21, 2023
Residents in Action – Current Surgical (BioBuzz) / PR Newswire
View
February 28, 2023
Medtech startup Current Surgical just landed a $3.2M seed round for its cancer treatment tech / Technical.ly
View
February 21, 2023
Current Surgical announces $3.2M seed raise, led by True Ventures / PR Newswire
View
February 21, 2023
Current Surgical is developing a ‘smart’ needle designed to treat cancerous tumors / TechCrunch
View
July 12, 2023

Current Surgical Receives $400k Grant from NIH's National Cancer Institute to Develop Surgery Platform for Early-Stage Cancer

View
June 21, 2023

Residents in Action – Current Surgical

BioBuzz

View
February 28, 2023

Medtech startup Current Surgical just landed a $3.2M seed round for its cancer treatment tech

Technical.ly

View
February 21, 2023

Current Surgical is developing a ‘smart’ needle designed to treat cancerous tumors

TechCrunch

View
February 21, 2023

Current Surgical announces $3.2M seed raise, led by True Ventures

View
September 28, 2022

Current Surgical Presents at the Inaugural Mayo Clinic Beahrs Surgical Innovation Summit

View
April 15, 2022

Current Surgical Joins Johnson & Johnson – JLABS at Washington, DC, as a Resident Company

View
January 24, 2022

Current Surgical Announces New Partnership with Sunstone Management

View
December 9, 2021

Inaugural Born in California® Event Creates Culture of Collaboration Among UC Schools

UCI Beall Applied Innovation

View
July 1, 2021

Current Surgical completes Johns Hopkins University NSF I-Corps program and receives non-dilutive site grant

View
June 24, 2021

Current Surgical Wants to Give Surgeons Superpowers

UCI Beall Applied Innovation

View
June 15, 2021

Current Surgical Selected for the MedTech Innovator 2021 Accelerator

View
May 12, 2021

Current Surgical Awarded Competitive Grant from the National Science Foundation

View
April 9, 2021

Current Surgical Accepted into Inaugural Class of SciFounder Fellowship Program

View
June 30, 2020

Current Surgical Joins the UCI Beall Applied Innovation's Wayfinder Incubator Program

View
Load More News